Free Trial

Procaps Group (PROC) SEC Filings & 10K Form

Procaps Group logo
$2.51 +0.07 (+2.87%)
(As of 12/20/2024 05:31 PM ET)

Recent Procaps Group SEC Filings

DateFilerForm TypeView
12/20/2024
4:00 PM
Procaps Group (Filer)
Procaps Group, S.A. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/03/2024
6:20 PM
Hoche Partners Pharma Holding S.A. (Filed by)
Procaps Group (Subject)
Procaps Group, S.A. (Subject)
Form SC 13D/A
12/03/2024
4:14 PM
Procaps Group (Filer)
Procaps Group, S.A. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/29/2024
8:29 AM
Procaps Group (Filer)
Procaps Group, S.A. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/15/2024
4:15 PM
Procaps Group (Filer)
Procaps Group, S.A. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/01/2024
3:30 PM
Procaps Group (Filer)
Procaps Group, S.A. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2024
8:46 PM
Hoche Partners Pharma Holding S.A. (Filed by)
Procaps Group (Subject)
Procaps Group, S.A. (Subject)
Form SC 13D/A
10/28/2024
7:42 PM
Hoche Partners Pharma Holding S.A. (Filed by)
Procaps Group (Subject)
Procaps Group, S.A. (Subject)
Form SC 13D/A
10/10/2024
8:44 PM
Hoche Partners Pharma Holding S.A. (Filed by)
Procaps Group (Subject)
Procaps Group, S.A. (Subject)
Form SC 13D/A
10/10/2024
4:30 PM
Procaps Group (Filer)
Procaps Group, S.A. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/08/2024
4:25 PM
Procaps Group (Filer)
Procaps Group, S.A. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/19/2024
5:15 AM
Hoche Partners Pharma Holding S.A. (Filed by)
Procaps Group (Subject)
Procaps Group, S.A. (Subject)
Form SC 13D/A
09/18/2024
7:15 AM
Procaps Group (Filer)
Procaps Group, S.A. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/04/2024
7:50 PM
Hoche Partners Pharma Holding S.A. (Filed by)
Procaps Group (Subject)
Procaps Group, S.A. (Subject)
Form SC 13D/A
09/03/2024
8:25 AM
Procaps Group (Filer)
Procaps Group, S.A. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/26/2024
8:25 AM
Procaps Group (Filer)
Procaps Group, S.A. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/23/2024
4:30 PM
Hoche Partners Pharma Holding S.A. (Filed by)
Procaps Group (Subject)
Procaps Group, S.A. (Subject)
Form SC 13D/A
08/08/2024
4:03 PM
Hoche Partners Pharma Holding S.A. (Filed by)
Procaps Group (Subject)
Procaps Group, S.A. (Subject)
Form SC 13D/A
07/29/2024
2:26 PM
Hoche Partners Pharma Holding S.A. (Filed by)
Procaps Group (Subject)
Procaps Group, S.A. (Subject)
Form SC 13D/A
07/22/2024
3:58 PM
Hoche Partners Pharma Holding S.A. (Filed by)
Procaps Group (Subject)
Procaps Group, S.A. (Subject)
Form SC 13D/A
07/10/2024
4:15 PM
Procaps Group (Filer)
Procaps Group, S.A. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2024
7:35 AM
Procaps Group (Filer)
Procaps Group, S.A. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2024
3:15 PM
Procaps Group (Filer)
Procaps Group, S.A. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/04/2024
7:11 AM
Procaps Group (Filer)
Procaps Group, S.A. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
10:39 AM
Hoche Partners Pharma Holding S.A. (Filed by)
Procaps Group (Subject)
Procaps Group, S.A. (Subject)
Form SC 13D/A
01/16/2024
7:36 AM
Procaps Group (Filer)
Procaps Group, S.A. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/12/2024
3:24 PM
Hoche Partners Pharma Holding S.A. (Filed by)
Procaps Group (Subject)
Procaps Group, S.A. (Subject)
Form SC 13D/A
01/05/2024
7:30 AM
Procaps Group (Filer)
Procaps Group, S.A. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/26/2023
4:25 PM
Procaps Group (Filer)
Procaps Group, S.A. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/26/2023
4:25 PM
Procaps Group (Filer)
Procaps Group, S.A. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PROC) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners